Last reviewed · How we verify
NCT03203629: HEARIT-Reg
Heart Sounds Registry
Completed
Last updated 23 April 2021
What this trial tests
trial testing Wearable Cardioverter Defibrillator (WCD) in Heart Failure; With Decompensation in 705 participants. Completed in 16 March 2021.
Timeline
5 June 2017
Primary endpoint
30 January 2020
30 January 2020
16 March 2021
Quick facts
| Lead sponsor | Zoll Medical Corporation |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 705 |
| Start date | 5 June 2017 |
| Primary completion | 30 January 2020 |
| Estimated completion | 16 March 2021 |
| Sites | 33 locations across Austria, United States, Germany, Poland |
Drugs / interventions tested
- Wearable Cardioverter Defibrillator (WCD)
Conditions studied
- Heart Failure; With Decompensation — all drugs for Heart Failure; With Decompensation →
Sponsor
Zoll Medical Corporation — full company profile →
Who can join
18 and older, any sex, with Heart Failure; With Decompensation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To conduct a prospective, observational study to evaluate the non-interventional feasibility of using heart sounds measurements recorded by the LifeVest® Wearable Cardioverter Defibrillator (WCD) for monitoring clinical evidence of heart failure decompensation.
Publications & conference data
7 peer-reviewed publications reference this trial (live from Europe PMC):
-
2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/A
Varma N, Cygankiewicz I, Turakhia MP, Heidbuchel H, et al · · 2021 · cited 46× · PMID 33573393 · DOI 10.1161/circep.120.009204 -
2021 ISHNE/ HRS/ EHRA/ APHRS collaborative statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia
Varma N, Cygankiewicz I, Turakhia M, Heidbuchel H, et al · · 2021 · cited 27× · PMID 33513268 · DOI 10.1111/anec.12795 -
Influence of decompensated heart failure on cardiac acoustic biomarkers: impact on early readmissions.
Erath JW, Wanczura P, Wranicz J, Linke A, et al · · 2020 · cited 14× · PMID 33063460 · DOI 10.1002/ehf2.13045 -
2021 ISHNE / HRS / EHRA / APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology / Heart Rhythm Society / European Heart Rhythm Associatio
Varma N, Cygankiewicz I, Turakhia M, Heidbuchel H, et al · · 2021 · cited 11× · PMID 36711170 · DOI 10.1093/ehjdh/ztab001 -
2021 ISHNE/HRS/EHRA/APHRS collaborative statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia Pac
Varma N, Cygankiewicz I, Turakhia M, Heidbuchel H, et al · · 2021 · cited 11× · PMID 33850572 · DOI 10.1002/joa3.12461 -
2021 ISHNE/HRS/EHRA/APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia Pac
Varma N, Cygankiewicz I, Turakhia MP, Heidbuchel H, et al · · 2021 · cited 9× · PMID 35265889 · DOI 10.1016/j.cvdhj.2020.11.004 -
Multiparameter Monitoring with a Wearable Cardioverter Defibrillator.
Rohrer U, Manninger M, Zirlik A, Scherr D. · · 2021 · cited 5× · PMID 35009564 · DOI 10.3390/s22010022
Verify or expand the search:
- PubMed search for NCT03203629
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Heart Failure; With Decompensation
Currently open trials in the same condition.
- NCT06592508 — Evaluation Of A Virtual Cardiology Program To Improve Outcomes After Acute Decompensated Heart Failure · NA · active not recruiting
- NCT06630923 — PREVENTION OF WORSENING RENAL FUNCTION OF INTRAVENUS ALBUMIN IN HEART FAILURE PATIENTS · Phase 3 · recruiting
- NCT05498584 — Targeting LOXL2 and Cardiac Fibrosis for Post-acute Heart Failure Treatment- A Prospective Study · recruiting
Other Zoll Medical Corporation trials
Trials by the same sponsor.
- NCT06313840 — Central Sleep Apnea Prevalence and Impact on Cognitive Function in Patients With Heart Failure With Reduced or Mildly Re · completed
- NCT05505136 — Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based · completed
- NCT05604430 — Pre-hospital Ventilation Clinical Study · enrolling by invitation
- NCT05073354 — Rapid Treatment of Shock Without Trauma · completed
- NCT05013333 — AED 3 Post-Approval Study · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
Data sources for this page
- Trial protocol + status: ClinicalTrials.gov NCT03203629 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zoll Medical Corporation
- Last refreshed: 23 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03203629.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing